Table 1 Summary of clinicopathological parameters of gastric cancer and their correlation with loss of MTSS1 protein expression
Features | No. of patients (%) | Loss of MTSS1 expression (%) | P value |
|---|---|---|---|
Tumor size | Â | Â | 0.005 |
   <6 cm | 825(77.0%) | 560(67.9%) |  |
   ≥6 cm | 247(23.0%) | 191(77.3%) |  |
Site | Â | Â | NS |
   Cardia and fundus | 180(16.8%) | 127(70.6%) |  |
   Corpus | 329(30.7%) | 229(69.6%) |  |
   Antrum | 519(48.4%) | 359(69.2%) |  |
   Whole | 44(4.1%) | 36(81.8%) |  |
pT stage | Â | Â | < 0.001 |
   T0-T2 | 312(29.1%) | 173(55.4%) |  |
   T3/T4 | 760(70.9%) | 578(76.1%) |  |
pN stage | Â | Â | < 0.001 |
   N0 | 356(33.2%) | 205(57.6%) |  |
   N1-3 | 716(66.8%) | 546(76.3%) |  |
Disease stage | Â | Â | < 0.001 |
   I/II | 427(39.8%) | 243(57%) |  |
   III/IV | 645(60.2%) | 508(78.8%) |  |
Differentiation | Â | Â | < 0.001 |
   Well/Moderate | 634(59.1%) | 399(62.9%) |  |
   Poorly | 438(40.9%) | 352(80.4%) |  |
Lauren's classification | Â | Â | < 0.001 |
   Intestinal-type | 618(57.6%) | 407(65.9%) |  |
   Diffuse-type | 454(42.4%) | 344(75.8%) |  |
Total | 1072 | 751(70.1%) | Â |